Feb 5 (Reuters) - Medical equipment maker Steris STE.N lowered its annual profit forecast on Wednesday, citing the impact of a stronger dollar.
The Dublin-based company lowered its fiscal 2025 adjusted profit to the range of $9.05 to $9.15 per share, from a prior forecast of $9.05 to $9.25 per share.
"This outlook does not reflect any potential impact from new tariffs." the company said.
Manufacturers of medical devices have been benefiting from elevated demand for elective surgical procedures in the United States, especially among older adults.
Steris, which produces surgical instruments, reported quarterly revenue of $1.37 billion, slightly below analysts' estimates of $1.38 billion, according to data compiled by LSEG.
The healthcare segment of the company, which provides sterilization products to healthcare providers, saw its quarterly revenue rise 7% in the third quarter ended December 31, to $976.0 million.
On an adjusted basis, the company reported a profit of $2.32 per share, which was in line with analysts' expectations.
(Reporting by Christy Santhosh in Bengaluru; Editing by Mohammed Safi Shamsi)
((Christy.Santhosh@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。